Protein Kinase D Signaling in Cancer: A Friend or Foe?

Overview

Journal Biochim Biophys Acta Rev Cancer

Publisher Elsevier

Specialties Biochemistry
Biophysics
Oncology

Date 2017 Jun 5

PMID 28577984

Citations 36

Authors

Adhiraj Roy

Jing Ye

Fan Deng

Qiming Jane Wang

Affiliations

Soon will be listed here.

Abstract

Protein kinase D is a family of evolutionarily conserved serine/threonine kinases that belongs to the Ca/Calmodulin-dependent kinase superfamily. Signal transduction pathways mediated by PKD can be triggered by a variety of stimuli including G protein-coupled receptor agonists, growth factors, hormones, and cellular stresses. The regulatory mechanisms and physiological roles of PKD have been well documented including cell proliferation, survival, migration, angiogenesis, regulation of gene expression, and protein/membrane trafficking. However, its precise roles in disease progression, especially in cancer, remain elusive. A plethora of studies documented the cell- and tissue-specific expressions and functions of PKD in various cancer-associated biological processes, while the causes of the differential effects of PKD have not been thoroughly investigated. In this review, we have discussed the structural-functional properties, activation mechanisms, signaling pathways and physiological functions of PKD in the context of human cancer. Additionally, we have provided a comprehensive review of the reported tumor promoting or tumor suppressive functions of PKD in several major cancer types and discussed the discrepancies that have been raised on PKD as a major regulator of malignant transformation.

Citing Articles

Mutant p53-Mediated Tumor Secretome: Bridging Tumor Cells and Stromal Cells.

Qiu L, Ma Z, Wu X Genes (Basel). 2025; 15(12.

PMID: 39766882 PMC: 11675497. DOI: 10.3390/genes15121615.

Phosphorylation of Optineurin by protein kinase D regulates Parkin-dependent mitophagy.

Weil R, Laplantine E, Attailia M, Oudin A, Curic S, Yokota A iScience. 2024; 27(12):111384.

PMID: 39669425 PMC: 11634986. DOI: 10.1016/j.isci.2024.111384.

Potential Prognostic Role of Protein Kinase D Isoforms in Head and Neck Cancers.

Gurbi B, Danos K, Birtalan E, Krenacs T, Kovacs B, Tamas L Int J Mol Sci. 2024; 25(19).

PMID: 39408603 PMC: 11477009. DOI: 10.3390/ijms251910274.

Comparative analysis of the mutational landscape and evolutionary patterns of pancreatic ductal adenocarcinoma metastases in the liver or peritoneum.

Yao G, Zhu Y, Liu C, Man Y, Liu K, Zhang Q Heliyon. 2024; 10(15):e35428.

PMID: 39170579 PMC: 11336646. DOI: 10.1016/j.heliyon.2024.e35428.

Internalized β2-Adrenergic Receptors Oppose PLC-Dependent Hypertrophic Signaling.

Wei W, Smrcka A Circ Res. 2024; 135(2):e24-e38.

PMID: 38813686 PMC: 11223973. DOI: 10.1161/CIRCRESAHA.123.323201.

References

Borges S, Doppler H, Perez E, Andorfer C, Sun Z, Anastasiadis P . Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis. Breast Cancer Res. 2013; 15(2):R66. PMC: 4052945. DOI: 10.1186/bcr3460. View

Wang Q, FANG T, Nacro K, Marquez V, Wang S, Blumberg P . Role of hydrophobic residues in the C1b domain of protein kinase C delta on ligand and phospholipid interactions. J Biol Chem. 2001; 276(22):19580-7. DOI: 10.1074/jbc.M010089200. View

Doppler H, Storz P . A novel tyrosine phosphorylation site in protein kinase D contributes to oxidative stress-mediated activation. J Biol Chem. 2007; 282(44):31873-81. DOI: 10.1074/jbc.M703584200. View

Doppler H, Bastea L, Borges S, Spratley S, Pearce S, Storz P . Protein kinase d isoforms differentially modulate cofilin-driven directed cell migration. PLoS One. 2014; 9(5):e98090. PMC: 4026536. DOI: 10.1371/journal.pone.0098090. View

Ellwanger K, Hausser A . Physiological functions of protein kinase D in vivo. IUBMB Life. 2013; 65(2):98-107. DOI: 10.1002/iub.1116. View

Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

Benjamin L, Keshet E . Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci U S A. 1997; 94(16):8761-6. PMC: 23118. DOI: 10.1073/pnas.94.16.8761. View

Weinreb I, Piscuoglio S, Martelotto L, Waggott D, Ng C, Perez-Ordonez B . Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands. Nat Genet. 2014; 46(11):1166-9. PMC: 10208689. DOI: 10.1038/ng.3096. View

Cowell C, Doppler H, Yan I, Hausser A, Umezawa Y, Storz P . Mitochondrial diacylglycerol initiates protein-kinase D1-mediated ROS signaling. J Cell Sci. 2009; 122(Pt 7):919-28. PMC: 2720927. DOI: 10.1242/jcs.041061. View

10.

Garraway L, Lander E . Lessons from the cancer genome. Cell. 2013; 153(1):17-37. DOI: 10.1016/j.cell.2013.03.002. View

11.

Hao Q, McKenzie R, Gan H, Tang H . Protein kinases D2 and D3 are novel growth regulators in HCC1806 triple-negative breast cancer cells. Anticancer Res. 2013; 33(2):393-9. View

12.

Dequiedt F, Van Lint J, Lecomte E, Van Duppen V, Seufferlein T, Vandenheede J . Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis. J Exp Med. 2005; 201(5):793-804. PMC: 2212830. DOI: 10.1084/jem.20042034. View

13.

Du C, Zhang C, Hassan S, Biswas M, Balaji K . Protein kinase D1 suppresses epithelial-to-mesenchymal transition through phosphorylation of snail. Cancer Res. 2010; 70(20):7810-9. DOI: 10.1158/0008-5472.CAN-09-4481. View

14.

Benjamin L, Golijanin D, Itin A, Pode D, Keshet E . Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest. 1999; 103(2):159-65. PMC: 407882. DOI: 10.1172/JCI5028. View

15.

Liou G, Doppler H, Braun U, Panayiotou R, Scotti Buzhardt M, Radisky D . Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasia. Nat Commun. 2015; 6:6200. PMC: 4394184. DOI: 10.1038/ncomms7200. View

16.

Yang Z, Rayala S, Nguyen D, Vadlamudi R, Chen S, Kumar R . Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchyme transition, modulates snail's subcellular localization and functions. Cancer Res. 2005; 65(8):3179-84. DOI: 10.1158/0008-5472.CAN-04-3480. View

17.

Sternlicht M, Lochter A, Sympson C, Huey B, Rougier J, Gray J . The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell. 1999; 98(2):137-46. PMC: 2853255. DOI: 10.1016/s0092-8674(00)81009-0. View

18.

Xu X, Gera N, Li H, Yun M, Zhang L, Wang Y . GPCR-mediated PLCβγ/PKCβ/PKD signaling pathway regulates the cofilin phosphatase slingshot 2 in neutrophil chemotaxis. Mol Biol Cell. 2015; 26(5):874-86. PMC: 4342024. DOI: 10.1091/mbc.E14-05-0982. View

19.

Johannes F, Prestle J, Eis S, Oberhagemann P, Pfizenmaier K . PKCu is a novel, atypical member of the protein kinase C family. J Biol Chem. 1994; 269(8):6140-8. View

20.

LaValle C, Bravo-Altamirano K, Giridhar K, Chen J, Sharlow E, Lazo J . Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility. BMC Chem Biol. 2010; 10:5. PMC: 2873968. DOI: 10.1186/1472-6769-10-5. View